Gastrointestinal Cancer
International
AMA PRA Category 1 Credits 1.00
CAMPEP Credits: 1.00
MDCB Credits: 1.00
Hidefumi Aoyama, MD, PhD
Hokkaido University Graduate School of Medicine
Sapporo, Hokkaido
Laura Dawson, MD, FASTRO
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Toronto, ON, Canada
The role of this session will review growing indications for radiation therapy for liver cancer, educate providers on radiation therapy options (SBRT, particle therapy) and the potential impact of hepatic reserve capacity on decision making, explore challenges and opportunities for clinical trials for liver cancer, discuss heterogeneous liver cancer patient populations, and lastly, discuss a case based HCC scenario to provide pertinent clinical context, and highlighting potential barriers to care including access to care and potential for financial toxicity. Liver cancer occurs on a background of liver disease in a heterogeneous group of people, including minority groups and underserved populations. Efforts will be made to emphasize equitable care and confounding factors that may be associated with biased outcomes following more expensive treatment. This session will be a joint ASTRO/JASTRO session that provides a unique opportunity to explore regional differences in patients, treatments and outcomes, as well as potential for fostering collaboration in liver cancer radiation therapy initiatives. The session will be of widespread interest to both community and academic radiation oncologists, as the indications for radiation therapy are expanding. It should also help radiation oncologists to become more aware of tools to aid in the selection and safe treatment of patients with liver cancer, and it should foster collaboration in the multidisciplinary management of this common, yet complicated disease, requiring team care.
Speaker: Laura Dawson, MD, FASTRO – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Speaker: Laura Dawson, MD, FASTRO – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Speaker: Tomoki Kimura, MD, PhD – Kochi University
Speaker: Masashi Mizumoto, MD, PhD – University of Tsukuba
Speaker: Jennifer Wo, MD – Massachusetts General Hospital
Speaker: Laura Dawson, MD, FASTRO – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Speaker: Hidefumi Aoyama, MD, PhD – Hokkaido University Graduate School of Medicine